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Abstract Cytomegalovirus (CMV) and Parvovirus B19
infections acquired during pregnancy may result in devel-
opmental disabilities of the foetus. This study evaluates the
occupational risk of these infections in female day care
personnel. IgG seroprevalence was determined in 310
Dutch day care workers and 158 nursing school students.
CMV seroprevalence was age-related, starting at 21% in
those <20 years and reaching 65% in those >35 years.
Between the ages of 20 and 24 years the CMV prevalence
was higher in day care personnel than in controls, 50%
versus 31% (p=0.03). In the first 2 years of employment
the risk of attracting CMV was significantly increased
(ORadj=3.80; p<0.001) and the occupational risk was also
increased (ORadj 2.19; p<0.001). Parvovirus seropositivity
(71–77%) was not related to age or working at a day care
centre. In conclusion, an occupational risk was observed for
CMV, but not for Parvovirus infection in female day care
personnel.
Introduction
Infections with Parvovirus B19—the causative agent of
erythema infectiosum or fifth disease—and Cytomegalovirus
(CMV) are global and common. Both infections have a
benign or asymptomatic course in the immunocompetent
host, while in the immunocompromised patient the viruses
can severely affect health. Another important risk group for
CMV and Parvovirus infections are pregnant women, with a
reported incidence that varies between 0.09 and 2% and 1
and 5% respectively [1, 2]. Since few newborns are screened
for CMV and Parvovirus, the true impact of congenital
CMV and Parvovirus infection is unknown. Intrauterine
transmission of CMV occurs in approximately 40% of the
primary CMV infections [3, 4]. Ten percent of these infected
infants present at birth with symptoms of irreversible central
nervous system involvement including microcephaly, en-
cephalitis, seizures, deafness, upper motor neuron disease
and mental retardation. In addition, 10–17% of the infants
that are asymptomatic at birth develop sensorineural hearing
loss or neurodevelopmental sequelae months to years
afterwards [5, 6]. Transplacental transmission rates of
Parvovirus have been estimated to be between 25 and
33%. Fetal infection with Parvovirus may lead to severe
anemia, generalised edema, congestive heart failure and
myocarditis, leading to fetal death in 5–9% of the cases, with
the greatest risk in the second trimester of pregnancy.
Approximately 60 and 30% of the women of childbear-
ing age in developed western European countries, such as
the Netherlands, are still susceptible to developing either a
primary CMV or Parvovirus infection [7, 8]. Nevertheless,
there are great variations in seroprevalence according to
geographical region, socioeconomic status and ethnic
composition [5]. Therefore, it is important to establish local
sero-epidemiology data to offer preventive strategies in a
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given country, as CMV and Parvovirus infections cannot
yet be prevented by immunisation and therapeutic options
are questionable. In the Netherlands, in a recent prospective
study, an unusually low incidence of congenital CMV
infection of 0.09% was reported [7]. The authors concluded
that preventive measures for CMV were thus not justified,
and that antenatal and perinatal counselling should be
reserved for (upcoming) Parvovirus epidemics. However,
this incidence is based on calculations in the general
population and small, potentially high-risk groups such as
day care workers will not be identified. Young children are
an important source of CMVor Parvovirus infection due to
poor hygiene. Up to 71% of children attending day care
centres may carry CMV in saliva or urine [9]. Direct and
indirect exposure of day care personnel by touching,
diapering, washing, feeding and contact with environmental
surfaces put them at a higher risk of acquiring a viral
infection [9, 10]. The aim of our study was to assess the
occupational risk of CMV and Parvovirus B19 infection in
female day care personnel in the Netherlands to determine
whether or not preventive measures (for instance, serolog-
ical testing followed by alternative work during pregnancy
being offered to women who test CMV-seronegative)
should be offered or not.
Materials and methods
Participants
Cytomegalovirus and Parvovirus IgG seroprevalence was
determined in 310 sera collected from 313 female day care
personnel from 66 regional day care facilities for children
in the southern part of the Netherlands between October
2000 and April 2003. Due to laboratory-related factors, 3
samples were not tested for CMV and Parvovirus. Written
consent to participation was obtained from all participants.
All women were asked to complete a questionnaire,
including data regarding age, work seniority, infant ages
of the care group, and the number and age of their own
children at home. Data were entered into a codified data-
base for analysis. One hundred and fifty-eight female
students, aged between 17 and 26 years, attending a nurse
school in the same region as the day care centres, served as
a control group. Data on their age and own children at
home were obtained.
Laboratory analysis
The outcome measure was seroprevalence for CMV and
Parvovirus infection. Sera were frozen at −20°C until testing
for CMV and Parvovirus IgG. CMV IgG was determined by
an automated microparticle enzymatic immunoassay AxSym
CMV IgG version (Abbott laboratories, Abbott Park, IL,
USA) and Parvovirus IgG was assayed using a third
generation Parvovirus IgG enzyme-linked immunoassay
(Biotrin, Dublin, Ireland). Both assays were performed
according to the manufacturer’s instructions. A value of
≥15 U/ml for CMV IgG was considered positive, whereas a
ratio of optical density sample to optical density cut-off (S/CO)
of more than 1 was considered positive for Parvovirus IgG.
Statistical analysis
Proportions between the groups were compared using Chi-
squared statistics. Associations were tested by univariate
and multiple logistic regression analysis, the latter allowing
adjustment for co-variables. The outcome variable of the
regression models was CMV IgG seropositivity versus
seronegativity. Parvovirus B19 was not considered in a
regression model as no interesting age-related features and
differences between groups were observed during the
explorative Chi-squared analyses. Two different regression
models were tested (Table 1). The first model tested the
main effect “occupational risk,” defined as being a day care
worker or student (= control). The second model tested the
main effect “work seniority” as defined by five categories
reflecting the number of years of day care employment
(0 years, 1–2 years, 3–4 years, 5–9 years, >9 years). Co-
variables in both models were “age” in years, “having own
children” as defined by parity (no children versus ≥1 child)
and “having children who were in contact with other
children” as defined by the presence of children at home
attending school or a day care centre (yes versus no). All
co-variables were simultaneously included in the logistic
regression model.
Results and discussion
The main finding of this study was that female day care
personnel have an increased risk of attracting a primo-
infection with CMV (ORadj 2.19, p<0.001; Table 1),
especially during the first 2 years of day care employment
(ORadj 3.80, p<0.001; Table 1). Furthermore, an age-
dependent increase in CMV IgG seropositivity was ob-
served for both day care workers and controls (Fig. 1a). Of
women younger than 19 years, 12.5% (1 out of 8) and 22%
(23 out of 104) respectively were positive for CMV IgG.
Fifty percent (40 out of 80) and 31% (16 out of 52; p=0.03)
of women aged between 21 and 24 years and 53% (31 out
of 58) and 50% (1 out of 2) of women aged between 25 and
29 years presented as CMV IgG-seropositive respectively.
In day care personnel aged between 30 and 34 years, 59%
(30 out of 51), and in the age group above 35 years, 65%
(73 out of 113) were CMV IgG-seropositive. No women
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older than 26 years were encountered in the control group.
Therefore, CMV seroprevalence data above this age are not
available in this group, which is a limitation of our study.
Age-dependent CMV seroprevalence has been described
before, with an annual seroconversion rate of 1% through-
out adulthood [3]. Therefore, similar age groups to those of
the day care personnel and the control group were
compared. In both study populations, the expected age-
dependent increase in CMV seroprevalence was observed;
however, this increase was greater in day care personnel
under 25 years of age than in the control population. The
fact that day care personnel are more likely to be exposed to
a CMV infection is additionally supported by the age-
adjusted associations between CMV seropositivity and day
care workers’ seniority found in the present study.
Work seniority was positively associated with an
increased risk of becoming CMV-seropositive (see also
Table 1), but when adjusting for age, having children and
children in day care or at school, only the first 2 years of
day care employment showed any significant influence. In
day care workers, CMV seroprevalence was associated with
having children at home (OR 2.79, p<0.001; Table 1) and
with having children attending a day care centre or a
primary school (OR 2.67, p<0.001; Table 1). However,
Table 1 Cytomegalovirus (CMV) seroprevalence in female day care personnel (n=310) and controls (n=158) and odds ratios calculated by
logistic regression analysis in female day care workers and controls
Total numbera Positive IgG CMV number (%) ORcrude 95% CI ORadj 95% CI
Model 1 Occupational risk
Control 158 40 (25) 1 1
Day care personnel 310 175 (57) 3.82 2.51–5.84 2.19 1.28–3.74
Parity; number of own children
0 302 111 (37) 1 1
≥1 160 99 (62) 2.79 1.88–4.15 0.76 0.34–1.66
Children in day care or at school
No 371 152 (41) 1 1
Yes 97 63 (65) 2.67 1.68–4.25 1.70 0.86–3.36
Age (years) - 0.96 0.93–0.99
Model 2 Work seniority (years)
0 158 40 (25) 1 1
1–2 78 36 (46) 2.53 1.43–4.48 3.80 1.53–9.38
3–4 69 32 (46) 2.55 1.41–4.62 2.06 0.93–4.58
5–9 90 57 (63) 5.10 2.91–8.91 2.04 0.93–4.50
>9 70 48 (69) 6.44 3.47–11.95 1.06 0.52–2.19
Parity; number of own children
0 302 111 (37) 1 1
≥1 160 99 (62) 2.79 1.88–4.15 0.69 0.31–1.54
Children in day care or at school
No 371 152 (41) 1 1
Yes 97 63 (65) 2.67 1.68–4.25 1.83 0.91–3.67
Age (years) – 0.97 0.94–1.01
OR = odds ratio; 95% CI = 95% confidence interval of odds ratio; ORcrude = crude odds ratio; ORadj = adjusted odds ratio
a Total group N=468, discrepant numbers are due to missing values
Fig. 1 a Age-related distribution of Cytomegalovirus seropositivity in
female day care personnel and controls. In the age group 20–24 years
the CMV seropositivity was significantly higher in day care personnel
than in controls (50 versus 31%; p=0.03 *). b Age-related distribution
of Parvovirus B12 seropositivity in female day care personnel and
controls. No relation was seen with regard to age and no difference
between day care personnel and controls was observed
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when adjusting for co-variables, these associations were no
longer significant (see Table 1).
Parvovirus serology was performed in both study
groups. No clear age-related increase in positive serology
was observed in either group (see Fig. 1b). Also, no overall
significant difference was seen between the two groups, as
the seroprevalence was 71% (n=319) and 77% (n=158)
respectively (p=0.224; Fig. 1b). The mean Parvovirus
seroprevalence of about 70% was comparable with the
seroprevalence of 70% measured in the Netherlands [8].
Parvovirus B19 is a highly contagious viral disease causing
erythema contagiosum, which is transmitted by droplets and
aerosols. Due to the general mode of transmission, all young
members of the general population are at increased risk of
acquiring the infection. According to a recent study in the UK,
antibody prevalence rose nonlinearly with age from 21% in
children aged 1–4 years to >75% in adults aged ≥5 years, with
the highest risk of acquiring infection being in those aged
<15 years [11]. Therefore, it is not surprising that there is no
occupational risk associated with Parvovirus B19.
The main limitation of our study was the fact that the
control group is different from the day care workers; it had
a limited age range (17–26 years) and the female students
mainly had no own children or exposure to young children.
The main purpose of the control group was therefore to
establish the occupational risk of CMVand Parvovirus B19
infection adjusted for age.
Our data are important as CMV is not considered a
public health problem in the Netherlands, whereas other
countries, such as the US, recognise that women within
certain professions like day care are more at risk of
acquiring a primary CMV infection during pregnancy [9,
10]. The rate of CMV IgG seropositivity found in our
control group mirrors the 35% observed in an earlier Dutch
study performed by Gaytant and coworkers [7]. Sixty-five
percent of Dutch women of childbearing age are thus still at
risk of attracting a CMV primo-infection. Nevertheless,
there appears to be little CMV-related morbidity in children
in the Netherlands. In a recent Dutch study performed in the
metropolitan agglomeration formed by the cities Amster-
dam, Rotterdam and The Hague, CMV seropositive neo-
nates were followed for 24 months. No significant
symptoms of CMV infection were observed in these infants
[7]. From studies outside the Netherlands it is known that
about 7–15% of asymptomatic infants will eventually
develop sensorineural hearing loss [5]. However, the
CMV seroprevalence in the Netherlands is lower than that
in the United States and other western European countries,
ranging from 40 to 83% [5]. Studies from other countries
have demonstrated that women working at child-care
centres are at increased risk of acquiring primo-CMV
infections [10], and our study confirms that this is also
the case in the Netherlands.
Cytomegalovirus infection, is mediated through contact
with infant saliva and urine, exposure mainly associated
with caring for young infants. Children who attend day care
centres are at a higher risk of acquiring infections due to
close contact and the sharing of toys and food. In addition,
infected children may excrete CMV for a prolonged time.
According to different reports, up to 50% of children
attending day care centres may excrete CMV [9].
Preconceptional maternal immunity (i.e., IgG seroposi-
tivity) has been demonstrated to protect against congenital
CMV [12, 13]; however, several studies have also pointed
out that recurrent CMV infections, as well as reactivation of
latent infections, may cause congenital CMV [12]. Our data
neglect the possibility of a recurrent CMV infection and the
true occupational risk of CMV infections will therefore be
even higher.
Hitherto, the only mode of prevention for congenital
CMV disease has consisted of increasing population
awareness and improvement of hygienic practices in those
at increased risk. The availability of a licensed and effective
CMV vaccine will probably take years and drug treatment
for pregnant women has not yet been extensively studied
because of concerns about toxicity. In a recent study, CMV
hyperimmune globulins were administered to CMV-
infected pregnant women [14]. Although the results
suggested that passive immunisation could prevent congenital
CMV infection, the results should be further substantiated in a
randomised and controlled trial. As such, women in contact
with small children, or those who are planning a pregnancy, at
least deserve to be informed how to prevent CMVacquisition
through improved personal hygiene [15]. Also, serological
screening of pregnant women who are at increased risk,
followed by offering alternative duties at work in those
tested negative, should be considered.
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